As of Apr 26
| -0.01 / -0.36%|
The 3 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +150.00% increase from the last price of 2.80.
The current consensus among 4 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.